Opko Health reported $267.2M in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US USD 116.57M 1.11M
Agios Pharmaceuticals AGIO:US USD 53.6M 5.2M
Akebia Therapeutics AKBA:US USD 187.96M 45.72M
Alnylam Pharmaceuticals ALNY:US USD 772.79M 115.11M
Amarin AMRN:US USD 287.36M 74.22M
Ardelyx ARDX:US USD 51.95M 3.25M
Arrowhead Research ARWR:US USD 138.85M 10.64M
Biomarin Pharmaceutical BMRN:US USD 521.02M 56.29M
Bluebird Bio BLUE:US USD 126.73M 22.13M
Bristol Myers Squibb BMY:US USD 18.93B 1.98B
Coherus Biosciences CHRS:US USD 171.32M 30.56M
Emergent Biosolutions EBS:US USD 268.4M 8.3M
Esperion Therapeutics ESPR:US USD 82.34M 70K
Exact Sciences EXAS:US USD 423.68M 19.65M
Exelixis EXEL:US USD 301.73M 2.79M
Halozyme Therapeutics HALO:US USD 109.38M 90.13M
Insmed INSM:US USD 137.65M 23.84M
Intercept Pharmaceuticals ICPT:US USD 221.58M 70.16M
Ironwood Pharmaceuticals IRWD:US USD 27.12M 3.82M
Laboratory Of America LH:US USD 2.52B 120.6M
Lexicon Pharmaceuticals LXRX:US USD 18.44M 1.58M
Moderna Inc MRNA:US USD 6.81B 5M
Myriad Genetics MYGN:US USD 129.1M 9.4M
Neurocrine Biosciences NBIX:US USD 485.1M 199.4M
Opko Health OPK:US USD 267.2M 51.73M
Ptc Therapeutics PTCT:US USD 420.08M 147.29M
Puma Biotechnology PBYI:US USD 59.99M 3.15M
Quest Diagnostics DGX:US USD 1.6B 25M
Sarepta Therapeutics SRPT:US USD 602.92M 57.35M
Seattle Genetics SGEN:US USD 726M 117.48M
Teva Pharmaceutical Industries TEVA:US USD 11.53B 538M
Ultragenyx Pharmaceutical RARE:US USD 227.36M 6.72M
United Therapeutics UTHR:US USD 315.9M 15.6M
Vanda Pharmaceuticals VNDA:US USD 92.62M 4.22M